M&A Deal Summary |
|
|---|---|
| Date | 2021-01-20 |
| Target | GlaxoSmithKline - The Clinical Laboratory Science |
| Sector | Life Science |
| Buyer(s) | Nexelis |
| Sellers(s) | GSK |
| Deal Type | Divestiture |
SEARCH BY
Nexelis is an immunology-centric CRO specialized in preclinical models and clinical assay development in single and multiplex formats and sample analysis for low-, mid- and large-scale clinical testing. the company's team of scientists and technology platforms have been instrumental in the development, qualification, and validation of assays supporting FDA filings of over 100 new molecular entities, including blockbuster biologics such as vaccines and complex large molecules.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 5 |
| Sector: Life Science M&A | 5 of 5 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Germany M&A | 1 of 1 |
| Year: 2021 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-07-22 |
AIT Bioscience
Indianapolis, Indiana, United States AIT Bioscience is an integrated bioanalytical laboratory with LC-MS and immunoassay testing capabilities which operates a paperless FDA-inspected facility supported by state-of-the-art electronic systems. AIT Bioscience is based in Indianapolis, Indiana. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1715 |
| Sector | Life Science |
| Employees | 68,629 |
| Revenue | 31.4B GBP (2024) |
GSK is a multinational pharmaceutical, biologics, vaccines and consumer healthcare company. GSK was founded in 1715 and is based in Brentford, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 23 of 24 |
| Sector: Life Science M&A | 16 of 17 |
| Type: Divestiture M&A Deals | 22 of 23 |
| Country: Germany M&A | 1 of 1 |
| Year: 2021 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-07-16 |
GSK Consumer Healthcare - seven brands
Brentford, United Kingdom GSK Consumer Healthcare's seven brands portfolio of products includes Breathe Right Nasal Strips and Children’s Dimetapp, pharmacist-recommended brand for children's cough and cold products, as well as Anbesol, Alavert, Dristan, Primatene Tablets and FiberCon. The addition of these brands will expand Foundation’s marketing presence to an additional 32 markets globally. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-02-11 |
GSK - Cephalosporin Antibiotics Business
Brentford, United Kingdom GSK's Cephalosporin Antibiotics Business is a provider of antibiotics used to treat a range of bacterial infections. |
Sell | $500M |
